Article
26 Sep 2025
Health Canada Aims To Reduce Red Tape By Increasing International Collaboration, Alignment And Reliance
AUTHORS CONTENT
Article
08 Jul 2025
CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary
Article
01 May 2025
Canada's Drug Agency Releases 2025 Watch List Highlighting AI Technologies In Health Care
Article
03 Apr 2025
Government Of Canada Announces First Pharmacare Agreements
Article
04 Mar 2025
Minister Of Health Announces New Bilateral Agreements With Provinces For Rare Disease Drugs
Article
04 Feb 2025
Competition Tribunal Refuses JAMP Leave To Commence Ustekinumab Abuse Of Dominance Application
Article
29 Nov 2024
Federal Court Denies Motion To Add Infringement Counterclaim To Ustekinumab Impeachment Action
Article
05 Nov 2024
Government Of Canada Passes Pharmacare Act
Article
03 May 2024
Federal Court Of Appeal Dismisses Appeal Of SPRAVATO "Innovative Drug" Decision
Article
05 Mar 2024
Dexlansoprazole Formulation Patent Invalid And Not Infringed By Apotex
Article
04 Mar 2024
Federal Court Of Appeal Affirms Minister Of Health Reasonable In Concluding Successor Second Person Was Entitled To Benefit Of NOA Served By Predecessor
Article
27 Dec 2023
Certificate Of Supplementary Protection Filing Fee Increase Effective April 1, 2024
Article
29 Nov 2023
Federal Court Finds No Procedural Unfairness In Minister Of Health's Decision That Smoking Cessation Aid Not A Natural Health Product
Article
31 Oct 2023
Minister Of Health Reasonable In Concluding Successor Second Person Was Entitled To Benefit Of NOA Served By Predecessor
Article
26 Sep 2023
CADTH Releases 2022-2023 Annual Report
Article
15 May 2023
Apotex's Section 8 Claim For Apo-Atomoxetine Dismissed
Article
11 May 2023
Supreme Court Of Canada Denies Apotex Leave To Appeal ONCA Olanzapine Statutes Of Monopolies Decision
Article
01 May 2023
Federal Court Dismisses Motion To Adjourn Section 8 Trial To Complete Document Production From Non-party Generics
Article
31 Mar 2023
Minister Of Health Announces National Strategy For Drugs For Rare Diseases
Article
03 Mar 2023
Federal Court Concludes Minister Of Health's Decision Not To Reassess Data Protection For SPRAVATO In View Of CUSMA Is Reasonable
